Literature DB >> 7998644

A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange?

E H Kaplan1, K Khoshnood, R Heimer.   

Abstract

The New Haven needle exchange program experienced a significant decline in the fraction of returned needles containing human immunodeficiency virus 1 (HIV-1) proviral DNA. Is this decline due to the operations of the needle exchange or to a shift in clients? Analysis of demographic and behavioral data revealed that only one variable, the race of participating clients, changed significantly over time. However, HIV-1 prevalences in needles given to Whites and to non-Whites were not statistically different. Thus, client shift cannot be responsible for the decline in the observed HIV prevalence in needles. Instead, needle circulation times were a significant predictor of HIV prevalence.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7998644      PMCID： PMC1615375          DOI： 10.2105/ajph.84.12.1991

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


  9 in total

1.  Prevalence of HIV-infected syringes during a syringe-exchange program.

Authors:  R Heimer; E H Kaplan; E C Cadman
Journal:  N Engl J Med       Date:  1992-12-24       Impact factor: 91.245

2.  Detection by polymerase chain reaction of human immunodeficiency virus type 1 proviral DNA sequences in needles of injecting drug users.

Authors:  R Heimer; S S Myers; E C Cadman; E H Kaplan
Journal:  J Infect Dis       Date:  1992-04       Impact factor: 5.226

3.  Racial/ethnic differences in the risk of AIDS in the United States.

Authors:  R M Selik; K G Castro; M Pappaioanou
Journal:  Am J Public Health       Date:  1988-12       Impact factor: 9.308

4.  HIV DNA and antibodies in syringes from injecting drug users: a comparison of detection techniques.

Authors:  S S Myers; R Heimer; D Liu; D Henrard
Journal:  AIDS       Date:  1993-07       Impact factor: 4.177

5.  Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut.

Authors:  R Heimer; E H Kaplan; K Khoshnood; B Jariwala; E C Cadman
Journal:  Am J Med       Date:  1993-08       Impact factor: 4.965

6.  Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus (HIV).

Authors:  K E Nelson; D Vlahov; S Cohn; M Odunmbaku; A Lindsay; J C Antohony; E W Hook
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

7.  Risk factors for human immunodeficiency virus infection in intravenous drug users.

Authors:  E E Schoenbaum; D Hartel; P A Selwyn; R S Klein; K Davenny; M Rogers; C Feiner; G Friedland
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

8.  Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City.

Authors:  M Marmor; D C Des Jarlais; H Cohen; S R Friedman; S T Beatrice; N Dubin; W el-Sadr; D Mildvan; S Yancovitz; U Mathur
Journal:  AIDS       Date:  1987-05       Impact factor: 4.177

Review 9.  Prevalence of HIV infection among intravenous drug users in the United States.

Authors:  R A Hahn; I M Onorato; T S Jones; J Dougherty
Journal:  JAMA       Date:  1989-05-12       Impact factor: 56.272
  9 in total
  9 in total

Review 1.  Structural interventions: concepts, challenges and opportunities for research.

Authors:  K M Blankenship; S R Friedman; S Dworkin; J E Mantell
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

2.  Annotation: needle exchange programs--do they work?

Authors:  R A Coutinho
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

3.  Harm reduction--a framework for incorporating science into drug policy.

Authors:  D C Des Jarlais
Journal:  Am J Public Health       Date:  1995-01       Impact factor: 9.308

4.  The evaluation of needle exchange programs.

Authors:  D Vlahov; R S Brookmeyer
Journal:  Am J Public Health       Date:  1994-12       Impact factor: 9.308

Review 5.  Syringe availability as HIV prevention: a review of modalities.

Authors:  P Coffin
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

6.  New pandemics: HIV and AIDS, HCV and chronic hepatitis, influenza virus and flu.

Authors:  Anne Gatignol; Jean Dubuisson; Mark A Wainberg; Eric A Cohen; Jean-Luc Darlix
Journal:  Retrovirology       Date:  2007-02-01       Impact factor: 4.602

Review 7.  Harm reduction in the USA: the research perspective and an archive to David Purchase.

Authors:  Don C Des Jarlais
Journal:  Harm Reduct J       Date:  2017-07-26

Review 8.  What is a vector?

Authors:  Anthony James Wilson; Eric René Morgan; Mark Booth; Rachel Norman; Sarah Elizabeth Perkins; Heidi Christine Hauffe; Nicole Mideo; Janis Antonovics; Hamish McCallum; Andy Fenton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-05-05       Impact factor: 6.237

9.  Return Rates for Needle Exchange Programs: A Common Criticism Answered.

Authors:  Kate Ksobiech
Journal:  Harm Reduct J       Date:  2004-04-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.